Toggle Summary |
Onconova Development Programs Highlighted in Seven Presentations at AACR Annual Meeting
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. Reports Fourth Quarter and Year-End 2013 Financial Results and Outlines Key Objectives for 2014
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. Announces Timing for Fourth Quarter and Year-End 2013 Financial Results and Conference Call
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. to Present at the Cowen and Company 34th Annual Health Care Conference
|
View HTML
|
Toggle Summary |
Onconova Announces Results From Phase 3 ONTIME Trial of Rigosertib in Higher Risk Myelodysplastic Syndromes (MDS)
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. to Present at 2014 Leerink Global Healthcare Conference
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. to Present at the 16th Annual BIO CEO & Investor Conference
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. to Host Webcast Regarding Insights Into Rigosertib Mechanism of Action With Scientific Founder, Dr. E. Premkumar Reddy
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference
|
View HTML
|
Toggle Summary |
Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer Study
|
View HTML
|
Toggle Summary |
Onconova Therapeutics to Host Analyst Event in New York City on December 19th
|
View HTML
|
Toggle Summary |
Onconova Announces Presentation of Positive Data From Clinical Trials of Rigosertib in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. to Present at the 25th Annual Piper Jaffray Healthcare Conference
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. Reports Third Quarter 2013 Financial and Operational Results
|
View HTML
|
Toggle Summary |
Onconova Announces Presentation of Rigosertib Clinical Data in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting
|
View HTML
|